Picture of Bavarian Nordic A/S logo

BAVA Bavarian Nordic A/S News Story

0.000.00%
dk flag iconLast trade - 00:00
HealthcareSpeculativeMid CapNeutral

Brief: Bavarian Nordic Announces UK Acceptance of Chikungunya Vaccine

March 7 (Reuters) - Bavarian Nordic A/S BAVA.CO:

BAVARIAN NORDIC ANNOUNCES ACCEPTANCE OF MARKETING AUTHORIZATION APPLICATION FOR CHIKUNGUNYA VACCINE IN THE UK FOR PERSONS AGED 12 AND OLDER

Source text: ID:nGNE4MHgXV

Further company coverage: BAVA.CO

 (Gdansk Newsroom)

 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))

Recent news on Bavarian Nordic A/S

See all news